Q3 2021
|
25 |
50,654 |
GILD, GSK, PFE, ALKS
|
13F-HR
|
11/15/2021 |
000091957421006956 |
Q2 2021
|
23 |
50,187 |
GILD, GSK, PFE, ALKS
|
13F-HR
|
8/16/2021 |
000091957421005307 |
Q1 2021
|
22 |
44,900 |
GILD, PFE, GSK, CLVSQ
|
13F-HR
|
5/17/2021 |
000091957421003613 |
Q4 2020
|
17 |
29,681 |
ABBV, GSK, VYNE, GILD
|
13F-HR
|
2/16/2021 |
000091957421001429 |
Q3 2020
|
18 |
30,344 |
GSK, JAZZ, GILD, ABBV
|
13F-HR
|
11/16/2020 |
000091957420007048 |
Q2 2020
|
19 |
39,167 |
GSK, GILD, PROSHARES TR, VYNE
|
13F-HR
|
8/14/2020 |
000091957420005187 |
Q1 2020
|
26 |
59,453 |
ABBV, GSK, GILD calls, GILD
|
13F-HR
|
5/15/2020 |
000091957420003506 |
Q4 2019
|
16 |
33,971 |
GSK, GILD, ABBV, CVS
|
13F-HR
|
2/14/2020 |
000091957420001552 |
Q3 2019
|
22 |
55,365 |
SPY puts, GILD, GSK, VIXY calls
|
13F-HR
|
11/14/2019 |
000091957419007158 |
Q2 2019
|
19 |
53,307 |
GILD calls, SPY puts, GSK, GILD
|
13F-HR
|
8/14/2019 |
000091957419005281 |
Q1 2019
|
10 |
25,955 |
AGN, GSK, TYME, GILD
|
13F-HR
|
5/14/2019 |
000091957419003373 |
Q4 2018
|
10 |
25,727 |
TYME, LAB, GSK, BIS
|
13F-HR
|
2/13/2019 |
000091957419001087 |
Q3 2018
|
12 |
41,349 |
GILD, AMRN, TYME, GSK
|
13F-HR
|
11/14/2018 |
000091957418007171 |
Q2 2018
|
13 |
35,275 |
GILD, TYME, NOVELION THERAPEUTICS INC, GSK
|
13F-HR
|
8/7/2018 |
000091957418005179 |
Q1 2018
|
9 |
24,060 |
GILD, TYME, NOVELION THERAPEUTICS INC, LAB
|
13F-HR
|
4/27/2018 |
000091957418003206 |
Q4 2017
|
11 |
32,884 |
TYME, GILD, GILD calls, NOVELION THERAPEUTICS INC
|
13F-HR
|
1/23/2018 |
000091957418000549 |
Q3 2017
|
13 |
49,972 |
TYME, PFE, NOVELION THERAPEUTICS INC, GILD
|
13F-HR
|
11/13/2017 |
000091957417007698 |
Q2 2017
|
17 |
55,652 |
PFE, NOVELION THERAPEUTICS INC, DEPOMED INC, GILD
|
13F-HR
|
8/10/2017 |
000091957417005822 |
Q1 2017
|
19 |
58,466 |
NOVELION THERAPEUTICS INC, PFE, SPY puts, GILD
|
13F-HR
|
5/12/2017 |
000091957417003983 |
Q4 2016
|
20 |
93,344 |
SPY puts, ANIP, PFE, NOVELION THERAPEUTICS INC
|
13F-HR
|
2/10/2017 |
000091957417001128 |
Q3 2016
|
20 |
63,135 |
ANIP, DEPOMED INC, PFE, DGX
|
13F-HR
|
11/10/2016 |
000091957416016214 |
Q2 2016
|
26 |
82,490 |
ANIP, SPY puts, DEPOMED INC, PFE
|
13F-HR
|
8/15/2016 |
000091957416014884 |
Q1 2016
|
30 |
68,078 |
ANIP, AMRI, PFE, SPY puts
|
13F-HR
|
5/16/2016 |
000091957416013178 |
Q4 2015
|
22 |
60,454 |
ANIP, AMRI, QLT INC, PFE
|
13F-HR
|
2/16/2016 |
000091957416011065 |
Q3 2015
|
28 |
70,123 |
ANIP, AMRI, AZN, QLT INC
|
13F-HR
|
11/16/2015 |
000091957415008098 |
Q2 2015
|
30 |
95,218 |
AMRI, QLT INC, BIS calls, MNKD puts
|
13F-HR
|
8/14/2015 |
000091957415006071 |
Q1 2015
|
36 |
91,756 |
AZN calls, AMRI, TWM, AZN
|
13F-HR
|
5/14/2015 |
000091957415004046 |
Q4 2014
|
26 |
54,712 |
AMRI, AZN, TEVA, DGX
|
13F-HR
|
2/13/2015 |
000091957415001370 |
Q3 2014
|
32 |
103,623 |
TWM, AMRI, ANIP, ACTAVIS PLC
|
13F-HR
|
11/13/2014 |
000091957414006217 |
Q2 2014
|
33 |
119,234 |
SPY puts, TWM calls, IWM puts, AMRI
|
13F-HR
|
8/13/2014 |
000091957414004398 |
Q1 2014
|
45 |
152,861 |
SPY puts, MDY puts, TWM calls, AMRI
|
13F-HR
|
5/13/2014 |
000091957414002902 |
Q4 2013
|
36 |
136,279 |
MDY puts, IBB puts, ANIP, SPY puts
|
13F-HR
|
2/13/2014 |
000091957414000867 |